T9V-11939-46353
4 vaccinations
5 coded responses
49 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-07
Registered in v-safe
-
2021-04-07
Dose 1 — Pfizer-BioNTech
- 2021-04-07
-
2021-04-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
-
2021-04-21
Survey response — day 14, dose 1MedDRA: Fatigue — Feeling: FairFree text: Tired bodyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Dose 2 — Pfizer-BioNTech
- 2021-04-28
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-30
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Excessive SweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Excessive sweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-05
- 2021-05-12
-
2021-05-19
Survey response — day 21, dose 2MedDRA: Chills — Feeling: GoodFree text: Sporadic ChillsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-26
- 2021-06-02
- 2021-06-09
- 2021-07-28
- 2021-10-27
-
2021-12-13
Dose 3 — Pfizer-BioNTech
- 2021-12-13
-
2021-12-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-16
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body achesAdult check-in
-
2021-12-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-12-18
- 2021-12-20
- 2021-12-27
- 2022-01-05
- 2022-01-19
- 2022-01-24
- 2022-03-14
-
2022-06-13
Survey response — 6 months, dose 3MedDRA: Cough, Oropharyngeal pain, Rhinorrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sore throat, runny nose, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-06-13
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-14
- 2022-06-17
-
2022-09-16
Dose 4 — Pfizer-BioNTech
-
2022-09-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-18
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
-
2022-09-19
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-09-20
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-09-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-22
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-12-16
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Pfizer-BioNTech | |
| 2 | 2021-04-28 | Pfizer-BioNTech | |
| 3 | 2021-12-13 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — day 14, dose 1
Symptoms: Tired body
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Excessive Sweating
Systemic reaction (other): Excessive sweating
Release 8 — day 21, dose 2
Symptoms: Sporadic Chills
Release 12 — 6 months, dose 3
Symptoms: Sore throat, runny nose, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release